Tramadol and Gilotrif drug interactions - a phase IV clinical study of FDA data
Summary:
Drug interactions are reported among people who take Tramadol (tramadol hydrochloride) and Gilotrif (afatinib dimaleate). Common drug interactions include rhinorrhoea among females and diarrhoea among males.
The phase IV clinical study analyzes what interactions people have when they take Tramadol and Gilotrif. It is created by eHealthMe based on reports of 67 people who take the same drugs from the FDA, and is updated regularly.
What is Tramadol?
Tramadol has active ingredients of tramadol hydrochloride. It is often used in pain. eHealthMe is studying from 235,798 Tramadol users. Check the latest studies of Tramadol.
What is Gilotrif?
Gilotrif has active ingredients of afatinib dimaleate. eHealthMe is studying from 6,055 Gilotrif users. Check the latest studies of Gilotrif.
67 people who take Tramadol and Gilotrif together, and have interactions are studied.

What are the common drug interactions of Tramadol and Gilotrif, by gender? *:
female:
- Rhinorrhoea (watery mucus discharge from the nose)
- Acne (skin problems that cause pimples)
- Onychoclasis (breaking of the nails)
- Vision blurred
- Alopecia (absence of hair from areas of the body)
- Corneal lesion (an injury to the living tissue of cornea)
- Feeding disorder (when children refuse to eat certain food groups)
- Fluid retention (an abnormal accumulation of fluid in the blood)
- Staphylococcal infection (an infection with staphylococcus bacteria)
- Swelling
male:
- Diarrhoea
- Rash
- Acne (skin problems that cause pimples)
- Dermatitis acneiform (dermatoses including acne vulgaris, rosacea, folliculitis, and perioral dermatitis)
- Pleural effusion (water on the lungs)
- Inflammation
- Mouth injury
- Swollen tongue (swelling of tongue)
- Dyspnoea (difficult or laboured respiration)
- Dyspepsia (indigestion)
What are the common drug interactions of Tramadol and Gilotrif, by age (0-1 to 60+)? *:
0-1:
n/a
2-9:
n/a
10-19:
n/a
20-29:
- Dermatitis (inflammation of the skin resulting from direct irritation by an external agent or an allergic reaction to it)
- Malignant neoplasm progression (cancer tumour came back)
- Metastases to meninges (cancer spreads to meninges)
- Somnolence (a state of near-sleep, a strong desire for sleep)
30-39:
n/a
40-49:
- Pruritus (severe itching of the skin)
- Rash
- Skin irritation
- Stomatitis (inflammation of mucous membrane of mouth)
- Drug ineffective
- Anxiety
50-59:
- Dyspnoea (difficult or laboured respiration)
- Emotional distress
- Myocardial infarction (destruction of heart tissue resulting from obstruction of the blood supply to the heart muscle)
- Paronychia (infection in the tissues adjacent to a nail on a finger or toe)
- Psoriasis (immune-mediated disease that affects the skin)
- Rash pustular (redness with pustules)
- Suicidal ideation
- Swelling face
- Vulvovaginal rash
60+:
- Diarrhoea
- Rash
- Alopecia (absence of hair from areas of the body)
- Arthralgia (joint pain)
- Myalgia (muscle pain)
- Pruritus (severe itching of the skin)
- Acne (skin problems that cause pimples)
- Abdominal pain upper
- Dehydration (dryness resulting from the removal of water)
- Dermatitis acneiform (dermatoses including acne vulgaris, rosacea, folliculitis, and perioral dermatitis)
What are the existing conditions these people have? *
- Lung Cancer - Non-Small Cell (lung cancer): 40 people, 59.70%
- High Blood Pressure: 14 people, 20.90%
- Lung Neoplasm Malignant (cancer tumour of lung): 13 people, 19.40%
- Non-Small Cell Lung Cancer Metastatic (type of epithelial lung cancer spreads to other parts): 7 people, 10.45%
- Lung Adenocarcinoma (a form of non-small cell lung cancer): 6 people, 8.96%
- Anaemia (lack of blood): 4 people, 5.97%
* Approximation only. Some reports may have incomplete information.
Do you take Tramadol and Gilotrif?
- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously
Related studies:
Effectiveness of, side effects of, and alternative drugs to the 2 drugs:
Browse all drug interactions of Tramadol and Gilotrif:
a b c d e f g h i j k l m n o p q r s t u v w x y zSub-studies by gender and age:
Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+
Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+
Browse all side effects of Tramadol:
a b c d e f g h i j k l m n o p q r s t u v w x y zBrowse all side effects of Gilotrif:
a b c d e f g h i j k l m n o p q r s t u v w x y zBrowse all interactions between Tramadol and drugs from A to Z:
a b c d e f g h i j k l m n o p q r s t u v w x y zBrowse all interactions between Gilotrif and drugs from A to Z:
a b c d e f g h i j k l m n o p q r s t u v w x y zRelated publications that referenced our studies
- Mansour HM, "Tramadol and Disseminated Intravascular Coagulopathy: A Case Report", Medicine Science, 2015 Jan .
- Mansour HM, "Tramadol and Disseminated Intravascular Coagulopathy: A Case Report", Medicine Science, 2015 Jan .
How the study uses the data?
The study uses data from the FDA. It is based on tramadol hydrochloride and afatinib dimaleate (the active ingredients of Tramadol and Gilotrif, respectively), and Tramadol and Gilotrif (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.
How to use the study?
DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.
Who is eHealthMe?
With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).
WARNING, DISCLAIMER, USE FOR PUBLICATION
WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.
DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.
If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.
Recent studies on eHealthMe:
- Drug interactions of Artane and Navane - 2 seconds ago
- How effective is Mestinon for Myasthenia Gravis? - 3 seconds ago
- Could Norepinephrine Bitartrate cause Overdose? - 4 seconds ago
- Drug interactions of Tobramycin and Ceftazidime - 10 seconds ago
- Could Nizoral cause Drug Effect Decreased? - 11 seconds ago
- Could Oxycontin cause Metabolic Disorder? - 17 seconds ago
- Could Uloric cause Nasal Congestion? - 17 seconds ago
- Drug interactions of Omeprazole and Nexletol - 20 seconds ago
- Could Propofol cause Fainting? - 21 seconds ago
- Drug interactions of Ceftazidime and Glivec - 22 seconds ago